Chronic Fatigue Syndrome: The Current Status and Future Potentials of Emerging Biomarkers.

  title={Chronic Fatigue Syndrome: The Current Status and Future Potentials of Emerging Biomarkers.},
  author={David B. Fischer and Arsani Hany William and Adam Strauss and Elizabeth R. Unger and Leonard A. Jason and Gailen D. Marshall and Jordan D. Dimitrakoff},
  journal={Fatigue : biomedicine, health & behavior},
  volume={2 2},
Chronic fatigue syndrome (CFS) remains an incompletely characterized illness, in part due to controversy regarding its definition, biological basis and diagnosis. Biomarkers are objective measures that may lead to improvements in our understanding of CFS by providing a more coherent and consistent approach to study, diagnosis and treatment of the illness. Such metrics may allow us to distinguish between CFS subtypes - each defined by characteristic biomarkers - currently conflated under the… CONTINUE READING
Highly Cited
This paper has 34 citations. REVIEW CITATIONS
Related Discussions
This paper has been referenced on Twitter 21 times. VIEW TWEETS

From This Paper

Topics from this paper.


Publications citing this paper.
Showing 1-10 of 13 extracted citations

Myalgic Encephalomyelitis: Symptoms and Biomarkers

Current neuropharmacology • 2015
View 4 Excerpts
Highly Influenced

CNS findings in chronic fatigue syndrome and a neuropathological case report.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research • 2017

Similar Papers

Loading similar papers…